NOT KNOWN FACTUAL STATEMENTS ABOUT AZELAPRAG AMGEN

AMG 986 exposures improved nonlinearly with rising doses; negligible accumulation was noticed. In HF with decreased ejection fraction sufferers, there were numerical will increase in per cent changes from baseline in LV ejection fraction and stroke volume by volumetric evaluation with AMG 986 vs placebo (stroke quantity maximize not recapitulated b